PET-Based Novel Imaging Techniques with Recently Introduced Radiotracers, An Issue of PET Clinics

1st Edition, Volume 16-2 - March 4, 2021
Editors: Mona-Elisabeth R. Revheim, Abass Alavi
Language: English
Hardback ISBN:
9 7 8 - 0 - 3 2 3 - 7 8 9 5 7 - 8
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 7 8 9 5 8 - 5

This issue of PET Clinics focuses on PET-Based Novel Imaging Techniques with Recently Introduced Radiotracers and is edited by Drs. Mona-Elisabeth R. Revheim and Abass Alavi.… Read more

PET-Based Novel Imaging Techniques with Recently Introduced Radiotracers, An Issue of PET Clinics

Purchase options

Info / Buy

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

This issue of PET Clinics focuses on PET-Based Novel Imaging Techniques with Recently Introduced Radiotracers and is edited by Drs. Mona-Elisabeth R. Revheim and Abass Alavi. Articles will include: Prostate-Specific Membrane Antigen PET in Prostate Cancer: 68Ga/18F labelled; Critical Role of FDG in Hormonally Active Malignancies; Role of Amino-Acid Tracers and FDG in the Diagnosis of Brain Tumors; FACBC/Fluciclovine PET Imaging in Prostate Cancer; Somatostatin PET in NEN: DOTA-peptides + 68Ga/64Cu labelled; Imaging of Insulinoma with PET: DOTA-peptides, Exendin-4 PET/CT; Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation; Molecular Imaging of Movement Disorders; Imaging of Cardiac Amyloidosis; and more!

Cover image
Title page
Table of Contents
Copyright
Contributors
Forthcoming Issues
CME Accreditation Page
Preface
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
Key points
Background
Evidence acquisition
Evidence synthesis
Discussion
18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
Key points
Background
Evidence acquisition
Evidence synthesis
Diagnostic accuracy
Discussion
Critical Role of 2-[18F]-fluoro-2-deoxy-glucose in Hormonally Active Malignancies
Key points
Introduction
Breast cancer
Thyroid cancer
Neuroendocrine tumors
Prostate cancer
Summary
Somatostatin Receptor Imaging PET in Neuroendocrine Neoplasm
Key points
Introduction
Neuroendocrine neoplasms
Somatostatin receptors
Somatostatin receptor imaging
Antagonists
Performane of the Somatostatin Receptor Pet Imaging Tracers
Value of somatostatin receptor imaging PET versus other anatomic imaging
Prognostic value of somatostatin receptor imaging
Other imaging tracers for neuroendocrine neoplasms
Discussion
Summary
Clinics care points
Imaging of Insulinoma by Targeting Glucagonlike Peptide-1 Receptor
Key points
Introduction of insulinoma
Glucagonlike peptide-1 receptor
Exendin-4: analogue of glucagonlike peptide-1
Glucagonlike peptide-1 receptor imaging in insulinomas
Pitfalls of glucagonlike peptide-1receptor imaging
Perspective of glucagonlike peptide-1 receptor imaging
Summary
Clinics care point
A Critical Review of PET Tracers Used for Brain Tumor Imaging
Key points
Introduction
Tumor delineation
Tumor grading
Response to treatment
Prognosis
Alternative PET tracers
Discussion
Clinics care points
Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation
Key points
Introduction
PET biomarkers of microglial and astrocyte activation: translocator protein and monoamine oxidase B
Goals
Experimental approach
Outcomes of preclinical studies
Discussion
Future directions
Summary
Conflict of interest
Tau Imaging in Head Injury
Key points
Introduction
Neuropathology of tau proteins in head injury
Tau radiotracers in head injury
Tau PET imaging studies in head injury
Summary
Clinics care points
Molecular Imaging of Neurodegenerative Parkinsonism
Key points
Introduction
Molecular imaging of parkinsonian neurodegenerations
Discussion
Future directions
Summary
Clinics care points
Non-18F-FDG/18F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature
Key points
Introduction
Atherosclerosis
Inflammatory disorders of the heart
Infectious diseases of the heart
Potential for non-18F-FDG/18F-NaF tracers in cardiovascular medicine
Clinics care points
Radionuclide Imaging of Cardiac Amyloidosis
Key points
Introduction
Pathobiology and prognosis
Diagnosis
Non–amyloid-specific radiotracers (bone scintigraphy)
Amyloid-specific probes
Clinical applications and future directions
Clinics care points
Novel Musculoskeletal and Orthopedic Applications of 18F-Sodium Fluoride PET
Key points
Introduction
Musculoskeletal trauma
Arthropathies
Back pain
Orthopedic complications
Metabolic bone diseases
Other osseous and soft tissue disorders
Summary
Clinics care points